Pretransplantation Direct-acting Antivirals Provides a Safe and Effective without Increase Recurrence of Hepatocellular Carcinoma in HCV-related HCC Patients

被引：0
|
作者：
Yin, S. M. [1 ]
Chen, C. L. [1 ]
Lin, C. C. [1 ]
Wang, C. C. [1 ]
Wang, S. H. [1 ]
Liu, Y. W. [1 ]
Yong, C. C. [1 ]
Lin, T. L. [1 ]
Li, W. F. [1 ]
Lin, Y. H. [1 ]
Chan, Y-C [1 ]
Yeh, C-S [1 ]
机构：
[1] Kaohsiung Chang Gung Mem Hosp, Gen Surg, Kaohsiung, Taiwan
来源：
TRANSPLANTATION | 2017年 / 101卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
O-59
引用
收藏
页码：42 / 43
页数：2
相关论文
共 50 条
  • [1] Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals
    Conti, Fabio
    Buonfiglioli, Federica
    Scuteri, Alessandra
    Crespi, Cristina
    Bolondi, Luigi
    Caraceni, Paolo
    Foschi, Francesco Giuseppe
    Lenzi, Marco
    Mazzella, Giuseppe
    Verucchi, Gabriella
    Andreone, Pietro
    Brillanti, Stefano
    JOURNAL OF HEPATOLOGY, 2016, 65 (04) : 727 - 733
  • [2] Impact of direct-acting antivirals on early recurrence of HCV-related HCC: Comparison with interferon-based therapy
    Kinoshita, Mizuki Nishibatake
    Minami, Tatsuya
    Tateishi, Ryosuke
    Wake, Taijiro
    Nakagomi, Ryo
    Fujiwara, Naoto
    Sato, Masaya
    Uchino, Koji
    Enooku, Kenichiro
    Nakagawa, Hayato
    Asaoka, Yoshinari
    Shiina, Shuichiro
    Koike, Kazuhiko
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : 78 - 86
  • [3] Improved recurrence-free survival rates in patients with HCV-related hepatocellular carcinoma and sustained virological response to direct-acting antivirals
    Muzica, Cristina-Maria
    Trifan, Anca
    Huiban, Laura
    Stoica, Oana
    Girleanu, Irina
    Chiriac, Stefan
    Singeap, Ana-Maria
    Cojocariu, Camelia
    Cuciureanu, Tudor
    Zenovia, Sebastian
    Nastasa, Robert
    Stanciu, Carol
    JOURNAL OF HEPATOLOGY, 2022, 77 : S573 - S574
  • [4] Direct-Acting Antivirals and Recurrence of Hepatocellular Carcinoma
    Marrero, Jorge A.
    Singal, Amit G.
    LIVER TRANSPLANTATION, 2017, 23 (09) : 1099 - 1100
  • [5] Immune inflammation indicators and ALBI score to predict occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals
    Gardini, A. C.
    Foschi, F. G.
    Conti, F.
    Petracci, E.
    Marisi, G.
    Buonfiglioli, F.
    Ravaioli, M.
    Mazzella, G.
    Muratori, P.
    Lenzi, M.
    Crespi, C.
    Bolondi, L.
    Badia, L.
    Verucchi, G.
    Vitale, G.
    Vukotic, R.
    Brillanti, S.
    Andreone, P.
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (01) : 50 - 51
  • [6] Risk of hepatocellular carcinoma (HCC) recurrence in HCV cirrhotic patients treated with Direct Acting Antivirals (DAAs)
    Cabibbo, G.
    Cacciola, I.
    Cannavo, M. R.
    Madonia, S.
    Calvaruso, V.
    Petta, S.
    Distefano, M.
    Larocca, L.
    Prestileo, T.
    Tine, F.
    Digiacomo, A.
    Bertino, G.
    Giannitrapani, L.
    Benanti, F.
    Davi, A.
    Volpes, R.
    Scalisi, I.
    Iacobello, C.
    Mazzola, G.
    Cartabellotta, F.
    Guarneri, L.
    Portelli, V.
    Averna, A.
    Russello, M.
    Scifo, G.
    Squadrito, G.
    Raimondo, G.
    Craxi, A.
    Di Marco, V.
    Camma, C.
    DIGESTIVE AND LIVER DISEASE, 2017, 49 (01) : E59 - E59
  • [7] Early occurrence of hepatocellular carcinoma (HCC) in patients with HCV cirrhosis treated with direct-acting antivirals (DAAs)
    Calvaruso, V.
    Cabibbo, G.
    Cacciola, I.
    Petta, S.
    Madonia, S.
    Bellia, A.
    Tine, F.
    Distefano, M.
    Giannitrapani, L.
    Prestileo, T.
    Mazzola, G.
    Davi, A.
    Larocca, L.
    Ardiri, A.
    Digiacomo, A.
    Gussio, M.
    Guarneri, L.
    Magro, A.
    Averna, A.
    Iacobello, C.
    Scalisi, I.
    Cartabellotta, F.
    Savalli, F.
    Russello, M.
    Scifo, G.
    Squadrito, G.
    Camma, C.
    Raimondo, G.
    Craxi, A.
    Di Marco, V.
    DIGESTIVE AND LIVER DISEASE, 2017, 49 (01) : E60 - E60
  • [8] Reversal of hypercoagulability in patients with HCV-related cirrhosis after treatment with direct-acting antivirals
    Russo, Francesco Paolo
    Zanetto, Alberto
    Campello, Elena
    Bulato, Cristiana
    Shalaby, Sarah
    Spiezia, Luca
    Gavasso, Sabrina
    Franceschet, Enrica
    Radu, Claudia
    Senzolo, Marco
    Burra, Patrizia
    Lisman, Ton
    Simioni, Paolo
    LIVER INTERNATIONAL, 2018, 38 (12) : 2210 - 2218
  • [9] Early occurence of hepatocellular carcinoma in patients with and without cirrhosis after HCV treatment with direct-acting antivirals
    Finkelmeier, F.
    Dultz, G.
    Kronenberger, B.
    Peiffer, K-H.
    Krauss, F.
    Zeuzem, S.
    Sarrazin, C.
    Vermehren, J.
    Waidmann, O.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 61 - 61
  • [10] Survival benefit of direct-acting antiviral agents on HCV-related HCC
    Chang, Shao-Hsuan
    Cabrera, Roniel
    Wilson, Debbie
    Park, Haesuk
    Park, Chanhyun
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 604 - 604
12345